scholarly journals Evaluation of Allergic Rhinitis and Asthma Control in a Portuguese Community Pharmacy Setting

2014 ◽  
Vol 20 (5) ◽  
pp. 513-522 ◽  
Author(s):  
Olga Lourenço ◽  
Sofia Calado ◽  
Ana Sá-Sousa ◽  
João Fonseca
Keyword(s):  
Allergic Rhinitis ◽  
Community Pharmacy ◽  
Asthma Control ◽  
Pharmacy Setting

Measuring the Assessment and Counseling Provided with the Supply of Nonprescription Asthma Reliever Medication: A Simulated Patient Study

2009 ◽  
Vol 43 (9) ◽  
pp. 1512-1518 ◽  
Author(s):  
Carl R Schneider ◽  
Alan W Everett ◽  
Elizabeth Geelhoed ◽  
Peter A Kendall ◽  
Rhonda M Clifford
Keyword(s):  
Community Pharmacy ◽  
Asthma Control ◽  
Simulated Patient ◽  
Simulated Patients ◽  
Community Pharmacies ◽  
Patient Assessment ◽  
Pharmacy Staff ◽  
Medication Counseling ◽  
Reliever Medication ◽  
Pharmacy Setting

Background: Over one quarter of asthma reliever medications are provided without prescription by community pharmacies in Australia. Evidence that community pharmacies provide these medications with sufficient patient assessment and medication counseling to ensure compliance with the government's Quality Use of Medicines principles is currently tacking. Objective: To assess current practice when asthma reliever medication is provided in the community pharmacy setting and to identify factors that correlate with assessment of asthma control. Methods: Researchers posing as patients visited a sample of Perth metropolitan community pharmacies in May 2007. During the visit, the simulated patient enacted a standardized scenario of someone with moderately controlled asthma who wished to purchase a salbutamol (albuterol) inhaler without prescription. Results of the encounter were recorded immediately after the visit. Regression analysis was performed, with medication use frequency (a marker of asthma control) as the dependent variable. Results: One hundred sixty community pharmacies in the Perth metropolitan area were visited in May 2007. Pharmacists and/or pharmacy assistants provided some form of assessment in 84% of the visits. Counseling was provided to the simulated patients in 24% of the visits. Only 4 pharmacy staff members asked whether the simulated patient knew how to use the inhaler. Significant correlation was found between assessment and/or counseling of reliever use frequency and 3 independent variables: visit length (p < 0.001), number of assessment questions asked (p < 0.001), and the simulated patient who conducted the visit (p < 0.02). Conclusions: Both patient assessment and medication counseling were suboptimal compared with recommended practice when nonprescription asthma reliever medication was supplied in the community pharmacy setting. Pharmacy and pharmacist demographic variables do not appear to affect assessment of asthma control. This research indicates the need for substantial improvements in practice in order to provide reliever medication in line with Quality Use of Medication principles of ensuring safe and effective use of medication.

Reliability of a Modified Medication Appropriateness Index in Community Pharmacies

2003 ◽  
Vol 37 (1) ◽  
pp. 40-46
Author(s):  
Rosemin Kassam ◽  
Linda G Martin ◽  
Karen B Farris ◽  
Homero A Monsanto ◽  
Jean-Marie Kaiser
Keyword(s):  
Community Pharmacy ◽  
Interrater Reliability ◽  
Intraclass Correlation ◽  
Community Setting ◽  
Medication Appropriateness Index ◽  
Paired Samples ◽  
Psychometric Data ◽  
Ambulatory Patients ◽  
Pharmacy Setting ◽  
Medication Appropriateness

Background The medication appropriateness index (MAI) has demonstrated reliability in selected outpatient clinics where medical data were easily accessible from medical charts. However, its use in the community setting where patient data may be limited has not been examined. Objective To evaluate the usefulness of a modified MAI for use in the community pharmacy setting by testing interrater reliability using 3 different rating schemes. Methods Two raters evaluated 160 medications for 32 elderly ambulatory patients. Patient information was acquired using community pharmacist-collected medication histories. A summated MAI score, percent agreement, κ, positive agreement, negative agreement, and intraclass correlation coefficient were calculated for each criterion using 3 scoring schemes. A paired samples t-test (95% CI) was used to test interrater reliability. Results The κ statistics were >0.75 for indication and effectiveness, but good (0.41–0.66) for the remaining criteria using the Hanlon scoring scheme. The intraclass coefficients (0.82, 0.86, 0.87) and overall κ (0.65, 0.66, 0.61) were similar for the 3 schemes. Conclusions This study suggests that the modified MAI has the potential to detect medication appropriateness and inappropriateness in the community pharmacy setting; however, it is not without limitations. Because the MAI has the most clinimetric and psychometric data available, the instrument should be studied further to increase its reliability and generalizability.

scholarly journals Group-Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting

2017 ◽  
Vol 103 (6) ◽  
pp. 1052-1060 ◽  
Author(s):  
Paul Dillon ◽  
Derek Stewart ◽  
Susan M. Smith ◽  
Paul Gallagher ◽  
Gráinne Cousins
Keyword(s):  
Older Adults ◽  
Community Pharmacy ◽  
Antihypertensive Medication ◽  
Trajectory Models ◽  
Pharmacy Setting

Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting

2010 ◽  
Vol 20 (4) ◽  
pp. 399-404 ◽  
Author(s):  
Søren Troels Christensen ◽  
Birthe Søndergaard ◽  
Per Hartvig Honoré ◽  
Ole Jannik Bjerrum
Keyword(s):  
Community Pharmacy ◽  
Adverse Drug Reactions ◽  
Pharmacy Student ◽  
Drug Reactions ◽  
Pharmacy Setting

scholarly journals The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting

PLoS ONE ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. e91157 ◽  
Author(s):  
Andrew Willis ◽  
Peter Rivers ◽  
Laura J. Gray ◽  
Melanie Davies ◽  
Kamlesh Khunti
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Community Pharmacy ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Cardiovascular Disease Risk Factors ◽  
Pharmacy Setting

Testing and treatment for hepatitis C in the community pharmacy setting: an opportunity not to be missed?

2020 ◽  
Vol 73 ◽  
pp. S324
Author(s):  
Nicki Palmer ◽  
Paul John ◽  
Kerry Rockey ◽  
Rhys Oakley ◽  
Brendan Healy
Keyword(s):  
Hepatitis C ◽  
Community Pharmacy ◽  
Pharmacy Setting
Sign in / Sign up

Export Citation Format

Share Document